|
Triguero A, Pedraza A, Perez-Encinas M, Mata-Vazquez MI, Velez P, Fox L, Gomez-Calafat M, Garcia-Delgado R, Gasior M, Ferrer-Marin F, Garcia-Gutierrez V, Angona A, Gomez-Casares MT, Cuevas B, Martinez C, Perez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernandez-Boluda JC, Sanz C, Alvarez-Larran A; On behalf of the MPN Spanish Group (GEMFIN). Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Oct;101(10):2231-2239. doi: 10.1007/s00277-022-04963-z. Epub 2022 Aug 30. Erratum In: Ann Hematol. 2022 Dec;101(12):2819-2820. PubMed PMID: 36042023; PubMed Central PMCID: PMC9584989.
AÑO: 2022; IF: 3.5
|
36042023
|
Ferrer-Marin F, Sola-Visner M. Neonatal platelet physiology and implications for transfusion. Platelets. 2022 Jan 2;33(1):14-22. doi: 10.1080/09537104.2021.1962837. Epub 2021 Aug 16. PubMed PMID: 34392772; PubMed Central PMCID: PMC8795471.
AÑO: 2022; IF: 3.3
|
|
Triguero A, Pedraza A, Perez-Encinas M, Mata-Vazquez MI, Velez P, Fox L, Gomez-Calafat M, Garcia-Delgado R, Gasior M, Ferrer-Marin F, Garcia-Gutierrez V, Angona A, Gomez-Casares MT, Cuevas B, Martinez C, Perez R, Raya JM, Guerrero L, Murillo I, Bellosillo B, Hernandez-Boluda JC, Sanz C, Alvarez-Larran A; On behalf of the MPN Spanish Group (GEMFIN). Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera. Ann Hematol. 2022 Dec;101(12):2819-2820. doi: 10.1007/s00277-022-05005-4. No abstract available. PubMed PMID: 36264368; PubMed Central PMCID: PMC9828814.
AÑO: 2022; IF: 3.5
|
|
Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, Mata-Vazquez MI, Bellosillo B, Arellano-Rodrigo E, Gomez M, Garcia R, Garcia-Gutierrez V, Gasior M, Cuevas B, Angona A, Gomez-Casares MT, Martinez CM, Magro E, Ayala R, Del Orbe-Barreto R, Perez-Lopez R, Fox ML, Raya JM, Guerrero L, Garcia-Hernandez C, Caballero G, Murillo I, Xicoy B, Ramirez MJ, Carreno-Tarragona G, Hernandez-Boluda JC, Pereira A; MPN Spanish Group (Grupo Espanol de Enfermedades Mieloproliferativas Filadelfia Negativas). Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. Cancer. 2022 Jul 1;128(13):2441-2448. doi: 10.1002/cncr.34195. Epub 2022 Apr 13. PubMed PMID: 35417564; PubMed Central PMCID: PMC9324831.
AÑO: 2022; IF: 6.2
|
|
Garcia-Fortes M, Hernandez-Boluda JC, Alvarez-Larran A, Raya JM, Angona A, Estrada N, Fox L, Cuevas B, Garcia-Hernandez MC, Gomez-Casares MT, Ferrer-Marin F, Saavedra S, Cervantes F, Garcia-Delgado R, On Behalf Of The Grupo Espanol de Enfermedades Mieloproliferativas Filadelfia Negativas Gemfin. Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis. Cancers (Basel). 2022 May 9;14(9):2331. doi: 10.3390/cancers14092331. PubMed PMID: 35565461; PubMed Central PMCID: PMC9104306.
AÑO: 2022; IF: 6.575
|